ATE337009T1 - Medizinische verwendung thyromimetischer verbindungen gegen haarausfall und zusammensetzungen - Google Patents

Medizinische verwendung thyromimetischer verbindungen gegen haarausfall und zusammensetzungen

Info

Publication number: ATE337009T1
Authority: AT; Austria
Prior art keywords: hair loss; compositions; medical use; thyromimetic compounds; compounds
Prior art date: 2001-05-31

Application number

AT02253607T

Other languages

English (en)

Inventor

Yuan-Ching Phoebe Chian

Peter Cornelius

Niall Stephen Doherty

Robert Lee Dow

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-31

Filing date

2002-05-22

Publication date

2006-09-15

2002-05-22 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE337009T1 publication Critical patent/ATE337009T1/de

Links

201000004384 Alopecia Diseases 0.000 title abstract 3
208000024963 hair loss Diseases 0.000 title abstract 3
230000003676 hair loss Effects 0.000 title abstract 3
150000001875 compounds Chemical class 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
230000000929 thyromimetic effect Effects 0.000 title abstract 2
241000124008 Mammalia Species 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
230000003779 hair growth Effects 0.000 abstract 1
244000144972 livestock Species 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

AT02253607T 2001-05-31 2002-05-22 Medizinische verwendung thyromimetischer verbindungen gegen haarausfall und zusammensetzungen ATE337009T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US29496201P	2001-05-31	2001-05-31

Publications (1)

Publication Number	Publication Date
ATE337009T1 true ATE337009T1 (de)	2006-09-15

Family

ID=23135661

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02253607T ATE337009T1 (de)	2001-05-31	2002-05-22	Medizinische verwendung thyromimetischer verbindungen gegen haarausfall und zusammensetzungen

Country Status (19)

Country	Link
US (2)	US20030007941A1 (de)
EP (1)	EP1262177B1 (de)
JP (1)	JP4051230B2 (de)
KR (1)	KR100523503B1 (de)
CN (1)	CN1314393C (de)
AT (1)	ATE337009T1 (de)
AU (1)	AU784806B2 (de)
CA (1)	CA2387198C (de)
CY (1)	CY1105221T1 (de)
DE (1)	DE60214080T2 (de)
DK (1)	DK1262177T3 (de)
ES (1)	ES2267945T3 (de)
HK (1)	HK1049285B (de)
HU (1)	HUP0201834A3 (de)
IL (2)	IL149843A (de)
PL (1)	PL354216A1 (de)
PT (1)	PT1262177E (de)
TW (1)	TWI278313B (de)
ZA (1)	ZA200204189B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6555581B1 (en)	2001-02-15	2003-04-29	Jones Pharma, Inc.	Levothyroxine compositions and methods
JP2004525109A (ja)	2001-02-15	2004-08-19	キング・ファーマシューティカルズ・インコーポレイティッド	安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en)	2001-08-14	2006-09-05	Franz G Andrew	Methods of administering levothyroxine pharmaceutical compositions
US7288257B2 (en)	2002-05-23	2007-10-30	Michael Powell	Diagnosis and treatment of human dormancy syndrome
US7485298B2 (en)	2002-05-23	2009-02-03	Michael Powell	Diagnosis and treatment of human dormancy-related sequellae
US7622103B1 (en) *	2003-03-27	2009-11-24	Cielo Jill M	Hair and scalp toxin remover composition and method of its making
ES2931949T3 (es)	2005-03-29	2023-01-05	Univ Pennsylvania	Minoxidilo para generar nuevos folículos pilosos y tratar la calvicie
US8147815B2 (en) *	2005-12-16	2012-04-03	Celmatrix Corporation	Topical administration carrier composition and therapeutic formulations comprising same
KR101396606B1 (ko)	2009-04-20	2014-05-16	미쓰비시 타나베 파마 코퍼레이션	신규 갑상선 호르몬 β 수용체 작동약
JP2014500275A (ja)	2010-12-06	2014-01-09	フォリカ，インコーポレイテッド	禿頭症を治療するため、および毛髪の成長を促進するための方法
JP6156371B2 (ja) *	2012-06-08	2017-07-05	大正製薬株式会社	発毛組成物
DK2695611T3 (en) *	2012-08-06	2015-01-05	Wolff August Gmbh & Co Kg Arzneimittel Dr	Eprotirome for use in the prevention and / or treatment of hair disorders and their compositions
US9827181B2 (en)	2013-06-05	2017-11-28	Industrial Technology Research Institute	Method and pharmaceutical composition for hair growth
US9402876B2 (en)	2013-11-27	2016-08-02	Industrial Technology Research Institute	Method and pharmaceutical composition for hair growth
CN104306168B (zh) *	2014-10-15	2017-05-24	华东师范大学	氮‑(4‑氯‑2,5‑二甲氧基苯基)‑5‑异丙基‑2‑甲氧基苯磺酰胺在促进毛发生长的应用
BR112019000706A8 (pt)	2016-07-15	2022-12-06	Pasteur Institut	Agente de estímulo do receptor 1b de 5-hidroxitriptamina para reparo de pele e/ou cabelo
US9962444B2 (en)	2016-09-27	2018-05-08	Shane Malek	Pharmacokinetically extended action topical hair growth formulation, and administration method
EP3683306A4 (de)	2017-09-14	2021-06-09	Riken	Verfahren zur herstellung von retinagewebe
CN108727344A (zh) *	2018-05-14	2018-11-02	嘉兴特科罗生物科技有限公司	一种化合物及其合成方法和应用
US11628132B2 (en)	2018-10-05	2023-04-18	Jupiter Wellness, Inc.	Minoxidil adjuvant therapies
US11766392B2 (en) *	2018-10-05	2023-09-26	Jupiter Wellness, Inc.	Minoxidil adjuvant therapies
US12533309B2 (en)	2018-10-05	2026-01-27	Caring Brands, Inc.	Minoxidil adjuvant therapies
SG11202109855PA (en)	2019-03-13	2021-10-28	Sumitomo Dainippon Pharma Co Ltd	Method for evaluating quality of transplant neural retina, and transplant neural retina sheet
WO2020227549A1 (en)	2019-05-08	2020-11-12	Aligos Therapeutics, Inc.	MODULATORS OF THR-β AND METHODS OF USE THEREOF
MX2022008626A (es)	2020-01-13	2022-08-22	Eccogene Shanghai Co Ltd	Triazinonas sustituidas como agonistas del receptor de la hormona tiroidea.
WO2022037617A1 (zh) *	2020-08-19	2022-02-24	成都凡诺西生物医药科技有限公司	腈代三嗪类衍生物及其制备方法和应用
JPWO2022054925A1 (de)	2020-09-11	2022-03-17
EP4201428A4 (de)	2020-09-11	2024-09-11	Sumitomo Pharma Co., Ltd.	Medium für gewebetransplantation
KR20240103018A (ko)	2021-11-19	2024-07-03	고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소	시트상 망막 조직의 제조 방법
CN116327765A (zh) *	2023-03-27	2023-06-27	广州许愿树毛发医学科技有限公司	莲心碱类化合物作为β2-肾上腺素受体阻断剂的应用
WO2025214484A1 (en) *	2024-04-12	2025-10-16	Ascletis Pharma (China) Co., Limited	Thyromimetics for treatment of alopecia areata

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3483385D1 (de) *	1983-08-17	1990-11-15	Wellcome Found	Physiologisch aktive zusammensetzungen.
JPS61165311A (ja) *	1985-01-14	1986-07-26	Takeo Kinji	養毛化粧料
US5061798A (en) *	1985-01-18	1991-10-29	Smith Kline & French Laboratories, Ltd.	Benzyl pyridyl and pyridazinyl compounds
US5284971A (en) *	1992-07-16	1994-02-08	Syntex (U.S.A.) Inc.	4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
JPH08509224A (ja) *	1993-04-20	1996-10-01	ザ、プロクター、エンド、ギャンブル、カンパニー	皮脂抑制および▲ざ▼瘡治療のためのヘスペレチンの使用方法
TW382595B (en) *	1993-10-15	2000-02-21	Merck & Co Inc	Pharmaceutical composition for use in arresting and reversing androgenic alopecia
WO1998032417A1 (en) *	1997-01-23	1998-07-30	Taisho Pharmaceutical Co., Ltd.	Persistent hair tonic
WO2000051971A1 (en) *	1999-03-01	2000-09-08	Pfizer Products Inc.	Oxamic acids and derivatives as thyroid receptor ligands
CO5160290A1 (es) *	1999-03-29	2002-05-30	Novartis Ag	Derivados de acido fenoxifeniloxamico sustituido .
JP2003500471A (ja) *	1999-06-01	2003-01-07	ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター	イオウ含有チロキシン誘導体及びそれらの毛髪成長促進剤としての使用
AU3507600A (en) *	1999-06-01	2000-12-18	University Of Texas Southwestern Medical Center, The	Substituted biaryl ether compounds
JP2003500432A (ja) *	1999-06-01	2003-01-07	ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター	ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
MXPA01012494A (es) *	1999-06-01	2002-07-02	Univ Texas Southwestern Med Ct	Metodo para tratar perdida capilar con el uso de compuestos sulfonil tiromimeticos.
EP1194422A1 (de) *	1999-06-01	2002-04-10	University Of Texas Southwestern Medical Center	Biarylverbindungen
DE60020786T2 (de) *	1999-09-30	2006-03-23	Pfizer Products Inc., Groton	6-Azauracilderivate als Liganden der Thyroidrezeptoren
CA2403806A1 (en) *	2000-03-23	2002-09-20	Bayer Aktiengesellschaft	Indoles for treating diseases that can be treated using thyroid hormones
AU2002223626A1 (en) *	2000-10-20	2002-04-29	Novartis Ag	Combinations of a thyromimetic compound and a statin

2002
- 2002-05-22 ES ES02253607T patent/ES2267945T3/es not_active Expired - Lifetime
- 2002-05-22 EP EP02253607A patent/EP1262177B1/de not_active Expired - Lifetime
- 2002-05-22 CA CA002387198A patent/CA2387198C/en not_active Expired - Fee Related
- 2002-05-22 PT PT02253607T patent/PT1262177E/pt unknown
- 2002-05-22 DK DK02253607T patent/DK1262177T3/da active
- 2002-05-22 DE DE60214080T patent/DE60214080T2/de not_active Expired - Lifetime
- 2002-05-22 AT AT02253607T patent/ATE337009T1/de not_active IP Right Cessation
- 2002-05-23 IL IL149843A patent/IL149843A/en not_active IP Right Cessation
- 2002-05-23 IL IL188110A patent/IL188110A0/en unknown
- 2002-05-27 ZA ZA200204189A patent/ZA200204189B/xx unknown
- 2002-05-30 CN CNB021216533A patent/CN1314393C/zh not_active Expired - Fee Related
- 2002-05-30 AU AU44462/02A patent/AU784806B2/en not_active Ceased
- 2002-05-30 US US10/160,516 patent/US20030007941A1/en not_active Abandoned
- 2002-05-30 TW TW091111565A patent/TWI278313B/zh not_active IP Right Cessation
- 2002-05-30 HU HU0201834A patent/HUP0201834A3/hu unknown
- 2002-05-31 JP JP2002159170A patent/JP4051230B2/ja not_active Expired - Fee Related
- 2002-05-31 PL PL02354216A patent/PL354216A1/xx unknown
- 2002-05-31 KR KR10-2002-0030677A patent/KR100523503B1/ko not_active Expired - Fee Related
2003
- 2003-02-25 HK HK03101401.8A patent/HK1049285B/zh not_active IP Right Cessation
2005
- 2005-03-24 US US11/089,146 patent/US20080125433A1/en not_active Abandoned
2006
- 2006-09-14 CY CY20061101319T patent/CY1105221T1/el unknown

Also Published As

Publication number	Publication date
ES2267945T3 (es)	2007-03-16
CA2387198A1 (en)	2002-11-30
TWI278313B (en)	2007-04-11
EP1262177A3 (de)	2003-09-03
EP1262177A2 (de)	2002-12-04
PL354216A1 (en)	2002-12-02
US20080125433A1 (en)	2008-05-29
CN1389203A (zh)	2003-01-08
AU784806B2 (en)	2006-06-29
IL149843A0 (en)	2002-11-10
JP2002370978A (ja)	2002-12-24
IL188110A0 (en)	2008-03-20
IL149843A (en)	2008-11-26
EP1262177B1 (de)	2006-08-23
HUP0201834A2 (hu)	2003-01-28
CY1105221T1 (el)	2010-03-03
DE60214080D1 (de)	2006-10-05
CN1314393C (zh)	2007-05-09
US20030007941A1 (en)	2003-01-09
JP4051230B2 (ja)	2008-02-20
KR20020092247A (ko)	2002-12-11
DK1262177T3 (da)	2006-11-20
HU0201834D0 (de)	2002-08-28
CA2387198C (en)	2007-02-13
HUP0201834A3 (en)	2004-03-29
PT1262177E (pt)	2006-12-29
HK1049285B (zh)	2007-08-24
ZA200204189B (en)	2003-11-27
KR100523503B1 (ko)	2005-10-26
HK1049285A1 (en)	2003-05-09
DE60214080T2 (de)	2007-01-04
AU4446202A (en)	2002-12-05

Legal Events

Date

Code

Title

Description

2007-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1262177

Country of ref document: EP

2010-02-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60214080D1 (de)	2006-10-05	Medizinische Verwendung thyromimetischer Verbindungen gegen Haarausfall und Zusammensetzungen
BR0211251B1 (pt)	2013-09-17	composição para o tratamento de cabelo e/ou couro cabeludo.
DE60235083D1 (de)	2010-03-04	Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE60033530D1 (de)	2007-04-05	Humane antikörper gegen ctla-4 und deren verwendungen
DE60232660D1 (de)	2009-07-30	Humane dr4-antikörper und deren anwendungen
ATE378403T1 (de)	2007-11-15	Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
DK0842934T3 (da)	2004-03-08	5-HT1F agonister
BRPI0410289A (pt)	2006-05-16	ligantes do receptor de canabinóides e suas utilizações
CY1110113T1 (el)	2015-01-14	Φωσφολιπιδιου παραγωγα βαλπροϊκου οξεος και μειγματα αυτων
CY1108078T1 (el)	2014-02-12	Παραγωγα του ν-θειο-νικοτιναμιδιου και συγγενεις ενωσεις για χρηση ως παρασιτοκτονα
ATE325789T1 (de)	2006-06-15	Aminocyclohexylether-verbindungen und deren verwendung
ATE336996T1 (de)	2006-09-15	Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
BR0201862A (pt)	2003-03-25	Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos
DE60234354D1 (de)	2009-12-24	Piperazinon-verbindungen als antitumorale und krebsbekämpfende mittel
DE50213398D1 (de)	2009-05-07	Verwendung bestimmter copolymere als adjuvans und mittel fur den agrotechnischen bereich
PL372769A1 (en)	2005-08-08	Cyanoguanidine prodrugs
ATE383874T1 (de)	2008-02-15	Perylenequinonen zur anwendung als sonosensitizer
ID25478A (id)	2000-10-05	Agonis 5-ht1f
ATE494307T1 (de)	2011-01-15	Neoplasma-spezifische antikörper und deren verwendungen
ATE345768T1 (de)	2006-12-15	Verbesserte lipidzusammensetzungen und darin enthaltene derivate des 3- methoxybenzylthioharnstoffs
EP1011664A4 (de)	2001-05-16	8a-AZALIDEN ALS ANTIMIKROBIELLE AGENTEN
DE60335093D1 (de)	2011-01-05	Verwendung von nichtantibakteriellen tetrazyklin-analoga und ihren formulierungen für die behandlung von bakteriellen exotoxinen
DE60334289D1 (de)	2010-11-04	Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
DE50105253D1 (de)	2005-03-10	Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)